OGEN INTELLIGENCE PHARMACEUTICAL COMPANY , Controlled-Release Drugs , Formulation , Repurposing Approach, Poly(orthoester)

OGEN INTELLIGENCE PHARMACEUTICAL COMPANY

Where Innovative Knowledge Meets Pharmaceutical Productions

Two Strategies Of Research & Development

This project aims to utilize international resources for further professional cooperation.

Drug

Improve the technology for drug development by
Machine learning & Artificial Intelligent

Formulations

Controlled Release Polymer, Formulations and
Products

Vision

Vision
AI &MA , Prediction and Future Concept

The reason we used predictive modeling such as AI and Repurposing in drug development

To predict biological activity and physico-chemical properties by rational means.
•To comprehend and rationalize the mechanisms of action within a series of chemicals.
•Savings in the cost of product development (e.g. in the pharmaceutical,).
•Predictions could reduce the requirement for lengthy and expensive animal tests.

Where Innovative Knowledge Meets Pharmaceutical Productions

What we do

OGEN INTELLIGENCE Pharmaceutical Company is located in Dubai, Emirate. OGEN designed and planned on research and development of highest international novel formulation research using Artificial intelligence, Machine Learning, Dynamic Simulations and Molecular Modeling in drug design.

Controlled release formulation based on microsphere, novel synthesized polymer, natural backbone have been fundamental research in R&D.